Search Results

Development of a HPLC fluorometric method for the quantification of enfuvirtide following in vitro releasing studies on thermosensitive in situ forming gel.

• Authors : Li H; School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, Belfast, BT9 7BL, UK.; Anjani QK

Subjects: Peptide Fragments*/Peptide Fragments*/Peptide Fragments*/chemistry ; HIV Fusion Inhibitors*/HIV Fusion Inhibitors*/HIV Fusion Inhibitors*/therapeutic use; Enfuvirtide

• Source: Drug delivery and translational research [Drug Deliv Transl Res] 2023 Aug; Vol. 13 (8), pp. 2183-2193. Date of Electronic Publication: 2023 Apr 29.Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium:

Record details

The use of the SAEM algorithm in MONOLIX software for estimation of population pharmacokinetic-pharmacodynamic-viral dynamics parameters of maraviroc in asymptomatic HIV subjects.

• Authors : Chan PL; Global Pharmacometrics, Pfizer Primary Care Business Unit, Sandwich, Kent, UK. ; Jacqmin P

Subjects: Algorithms* ; Models, Statistical*; Cyclohexanes/Cyclohexanes/Cyclohexanes/*pharmacokinetics

• Source: Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2011 Feb; Vol. 38 (1), pp. 41-61. Date of Electronic Publication: 2010 Nov 19.Publisher: Springer Country of Publication: United States NLM ID: 101096520 Publication Model: Print-Electronic Cited Medium:

Record details

[Pretreated HIV patients profit from Maraviroc. Oral HIV fusion inhibitor opens new therapy chances].

Subjects: Cyclohexanes/Cyclohexanes/Cyclohexanes/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2008 Apr 28; Vol. 150 Spec No 1, pp. 52-3.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print

Record details

[New kinds of AIDS drugs inhibit HIV entry into the cell. Entry inhibitors soon for oral administration].

• Authors : Fätkenheuer G; Klinik I für Innere Medizin--Infektio- logie, Universitäts-klinikum Köln.

Subjects: CCR5 Receptor Antagonists*; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2005 Apr 25; Vol. 147 Spec No 1, pp. 46-8.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print

Record details

[Fusion inhibitor enfuvirtidE. Continuous virologic and immunologic response].

• Authors : Schäfer B

Subjects: HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use ; HIV-1/HIV-1/HIV-1/*drug effects

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2005 Apr 25; Vol. 147 Spec No 1, pp. 31.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print

Record details

[Fusion inhibitors. One year therapy with T-20--initial evaluation].

• Authors : Goebel FD; Med. Poliklinik, Universität München.

Subjects: HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use ; HIV Infections/HIV Infections/HIV Infections/*drug therapy

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2004 Apr 26; Vol. 146 Spec No 1, pp. 42-3.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print

Record details

[Strategies for combating resistances in HIV therapy--an exemplifying case].

• Authors : Stoehr A; Institut für interdisziplinäre Infektiologie und Immunologie GmbH, Hamburg.

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Drug Resistance, Multiple, Viral/Drug Resistance, Multiple, Viral/Drug Resistance, Multiple, Viral/*drug effects ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2004 Apr 26; Vol. 146 Spec No 1, pp. 70-1.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print

Record details

[Entry inhibitors. Ring-free for a new principle of action].

• Authors : Rümmelein N; KIS-Kuratorium für Immunschwäche, München.; Jäger H

Subjects: Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/Acquired Immunodeficiency Syndrome/*drug therapy ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*administration & dosage ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*administration & dosage

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2003 Apr 28; Vol. 145 Spec No 1, pp. 16-20.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print

Record details

[Initial retroviral drug with new mechanism of action. Peptide T-20 enriches therapeutic arsenal].

Subjects: Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; HIV Envelope Protein gp41/HIV Envelope Protein gp41/HIV Envelope Protein gp41/*therapeutic use ; HIV Fusion Inhibitors/HIV Fusion Inhibitors/HIV Fusion Inhibitors/*therapeutic use

• Source: MMW Fortschritte der Medizin [MMW Fortschr Med] 2003 Apr 28; Vol. 145 Spec No 1, pp. 55-7.Publisher: Springer Country of Publication: Germany NLM ID: 100893959 Publication Model: Print Cited Medium: Print

Record details

The investigations on HIV-1 gp120 bound with BMS-488043 by using docking and molecular dynamics simulations.

• Authors : Li L; National Synchrotron Radiation Laboratory, University of Science and Technology of China, Hefei, 230029, People's Republic of China.; Chen H

Subjects: Molecular Docking Simulation* ; Molecular Dynamics Simulation*; Amino Acids/Amino Acids/Amino Acids/*chemistry

• Source: Journal of molecular modeling [J Mol Model] 2013 Feb; Vol. 19 (2), pp. 905-17. Date of Electronic Publication: 2012 Oct 20.Publisher: Springer Country of Publication: Germany NLM ID: 9806569 Publication Model: Print-Electronic Cited Medium:

Record details